Bacteriocin production in Streptococcus gallolyticus by a complex 4-component regulatory system with activator and anti-activator activities

Abstract

Bacteriocins are natural antimicrobial peptides produced by bacteria to kill closely related competitors. The opportunistic pathogen Streptococcus gallolyticus (Sgg) was recently shown to outcompete commensal enterococci of the murine microbiota in tumoral conditions thanks to the production of a two-peptide bacteriocin named gallocin. We here identified 4 genes involved in the regulatory control of gallocin in Sgg UCN34, respectively encoding a histidine kinase/response regulator two-component system (BlpH/BlpR), a secreted peptide (GSP), and a putative regulator of unknown function (BlpS). While BlpR is a typical 243-aa response regulator possessing a phospho-receiver domain and a LytTR DNA-binding domain, BlpS is a 108-aa protein containing only a LytTR domain. Our results showed that the secreted peptide GSP activates the dedicated two-component system BlpH/BlpR to induce gallocin transcription. A genome-wide transcriptome analysis indicates that this regulatory system (GSP-BlpH/BlpR) is highly specific for bacteriocin production. Importantly, as opposed to BlpR, BlpS was shown to repress gallocin gene transcription. A conserved operator DNA sequence of 30-bp was found in all promoter regions regulated by BlpR and BlpS. EMSA assays showed direct and specific binding of the two gallocin regulators to various regulated promoter regions in a dose dependent manner. Gallocin expression appears tightly controlled in Sgg by quorum sensing and antagonistic activity of 2 LytTR-containing proteins. SignificanceStreptococcus gallolyticus (Sgg), formely known as S. bovis biotype I, is an opportunistic pathogen causing septicemia and endocarditis in the elderly often associated with asymptomatic colonic neoplasia. We previously showed that Sgg produces a bacteriocin, termed gallocin, enabling colonization of the colon in tumoral conditions by outcompeting commensal members of the gut. Here we characterized a 4-component regulatory system that regulates gallocin transcription, which is activated by the response regulator BlpR. BlpR itself is activated by a quorum sensing peptide GSP and a dedicated histidine kinase BlpH. Interestingly, BlpS, a small DNA-binding protein co-transcribed with BlpR was found to repress gallocin genes transcription, likely by antagonizing BlpR. Understanding gallocin regulation is crucial to prevent Sgg colon colonization in tumoral conditions.